[How could the results of surgical treatment of bronchogenic carcinoma be improved? (authors transl)].
作者信息
Denck H
出版信息
Wien Klin Wochenschr. 1978 Apr 14;90(8):275-83.
PMID:636442
Abstract
摘要
相似文献
1
[How could the results of surgical treatment of bronchogenic carcinoma be improved? (authors transl)].如何提高支气管源性癌的外科治疗效果？（作者译）
Wien Klin Wochenschr. 1978 Apr 14;90(8):275-83.
2
[Preliminary evaluation of intermittent polychemotherapy in high doses for prevention of recurrence after radical operation of lung cancer (author's transl)].
Arch Geschwulstforsch. 1973;42(4):316-23.
3
[Chemotherapy of bronchial carcinomas (author's transl)].
Z Erkr Atmungsorgane. 1975 Feb;142(2):149-63.
4
Chemotherapeutic studies in bronchogenic carcinoma by the Austrian study group.
Cancer Chemother Rep 3. 1973 Mar;4(2):207-13.
5
[Five years treatment of advanced solid malignomas with a combination of four cytostatic drugs (author's transl)].四种细胞抑制剂联合治疗晚期实体恶性肿瘤五年（作者译）
Osterr Z Onkol. 1976 May;3(1-2):8-26.
6
[Polychemotherapy of bronchial carcinoma].
Minerva Med. 1970 Jun 9;61(46):2567-70.
7
High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trial.
Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1131-4.
8
Chemotherapy in recurrent heat and neck cancer.复发性头颈癌的化疗
Otolaryngol Clin North Am. 1974 Feb;7(1):205-15.
9
[Polychemotherapy of the advanced and metastasizing carcinoma of the breast].[晚期及转移性乳腺癌的多药化疗]
Fortschr Med. 1976 May 6;94(13):761-4.
10
Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.改良II期（T1 N1 M0、T2 N1 M0）非小细胞支气管源性癌的治疗。一种综合治疗方法。
J Thorac Cardiovasc Surg. 1983 Aug;86(2):180-5.
引用本文的文献
1
[Results of surgical treatment of bronchiogenic carcinoma and nonsurgical treatment of oat cell carcinoma (author's transl)].支气管源性癌的外科治疗及燕麦细胞癌的非手术治疗结果（作者译）
Langenbecks Arch Chir. 1980;351(2):77-84. doi: 10.1007/BF01237612.
Zotero 插件